Gene Therapy Under Scrutiny After Nine Tumor Reports

Summary
(MedPage Today) -- Drugmaker Novartis acknowledged Thursday that there have been nine reports of tumors in children treated with its gene therapy onasemnogene abeparvovec (Zolgensma) for spinal muscular atrophy (SMA). Two of the tumor cases were...
Description from Medpagetoday.
Who is covering this
-
Gene Therapy Under Scrutiny After Nine Tumor Reports
(MedPage Today) -- Drugmaker Novartis acknowledged Thursday that there have been nine reports of tumors in children treated with its gene therapy onasemnogene abeparvovec (Zolgensma) for spinal muscular atrophy (SMA). Two of the tumor cases were...
Comments
Comments need JavaScript.